Health information to help you understand symptoms. It isn't a diagnosis.
Check symptoms

Research deep dives

Nutrition and weight in ALS

Last reviewed November 16, 2026. OwieClear editorial team. Waiting for clinician review. Not medical advice. Talk with your doctor about your own care.

This is an unusual nutrition page, because for once the nutritional intervention is not a side issue. Weight loss in ALS is linked to faster progression, and preventing it appears to matter.

It is also an area where desperate hope meets heavy marketing, so the supplement section below is specific about which products have actually been tested and what the trials found.

Related pages: ALS (amyotrophic lateral sclerosis)

The bottom line

What we know
  • People with ALS often burn more energy at rest than expected.
  • Weight loss is associated with faster progression and shorter survival.
  • High-calorie nutrition is actively recommended rather than merely permitted.
  • A feeding tube is safer when placed before breathing becomes weak.
What is still open
  • Whether maintaining weight changes the course of the disease or reflects it.
  • The optimal composition of nutrition in ALS, which is still being studied.

The story, step by step

  1. 1. Hypermetabolism ()
  2. 2. Eating more ()
  3. 3. The feeding tube ()
  4. 4. The supplements ()
  5. 5. Where to spend effort ()
What the evidence labels mean
GuidelineAn official recommendation from an expert group after weighing all the evidence.
Review of many studiesCombines the results of many studies (a systematic review or meta-analysis).
Randomized trialPeople were randomly given a treatment or a comparison, the best way to test cause and effect.
Large observational studyFollows many people over time. Shows strong links, but not always cause and effect.
Small or early studyA small study, case series, or first results. Needs to be confirmed.
Lab or animal studyDone in cells or animals. May not apply to people.
Part 1 of 5

Burning more while doing less

Review of many studies

What happens

A substantial proportion of people with ALS have a higher resting metabolic rate than their body size predicts.

What the research shows

  • This is measurable and is not explained by the effort of moving with weakness.
  • Muscle itself may be metabolically abnormal in ALS, and mitochondrial dysfunction is a proposed explanation.
  • At the same time, eating becomes harder: swallowing tires, meals take longer, and arm weakness makes self-feeding difficult.
  • Higher demand and lower intake together produce weight loss, which is common.
  • Body mass index at diagnosis and weight change over time are both associated with survival in studies.

Why it matters

This is the opposite of most dietary advice. Here the goal is energy density, not restriction.

What's still uncertain

  • Whether hypermetabolism drives progression or is a consequence of it has not been settled.

Read more

Next: Eating more

Part 2 of 5

The practical approach

Review of many studies

What happens

The advice is specific and differs from general healthy eating guidance.

What the research shows

  • Higher calorie intake than usual, with an emphasis on energy density: adding fats and oils, full-fat dairy, nut butters, sauces and oral nutrition supplements.
  • Smaller, more frequent meals, because eating tires people who have bulbar weakness.
  • Texture modification as swallowing changes: softer foods, thickened liquids if thin liquids cause coughing. A speech and language therapist assesses this specifically.
  • Posture at meals, and techniques such as the chin tuck, reduce the risk of food going into the airway.
  • Referral to a dietitian experienced in ALS should happen at diagnosis rather than when weight has already fallen.

Why it matters

Being told to add cream and butter to food is disorienting after a lifetime of the opposite advice. In this condition it is the correct advice.

What's still uncertain

  • Trials of high-calorie feeding have shown promise, particularly in fast-progressing disease, but the evidence base is still modest.

Read more

Next: The feeding tube

Part 3 of 5

Timing matters more than the decision

Review of many studies

What happens

A gastrostomy tube, usually a PEG, is often raised earlier than people expect, and the timing is the point.

What the research shows

  • It is placed through the abdominal wall into the stomach, and it allows nutrition, fluids and medicines to be given without swallowing.
  • It does not mean someone must stop eating. Many people continue to eat what they enjoy and use the tube to make up the difference.
  • Placement involves sedation and is safer when breathing function is still relatively preserved, which is why it is discussed before it seems urgent.
  • Waiting until weight loss and breathing weakness are advanced makes the procedure riskier.
  • It is a decision the person makes, and discussing it early means it is made with time rather than under pressure.

Why it matters

The common regret is waiting. The tube is easier, safer and less disruptive when it is arranged ahead of need.

What's still uncertain

  • Evidence that a feeding tube prolongs survival is mixed; evidence that it helps maintain weight and reduce distress is stronger.

Read more

Next: The supplements

Part 4 of 5

What the trials actually found

Review of many studies

What happens

ALS attracts more supplement marketing than almost any condition, and several of the common recommendations have been formally tested.

What the research shows

  • Creatine: tested in several randomized trials in ALS. It did not slow progression or improve survival. This is a negative result from real trials, not an absence of evidence.
  • Coenzyme Q10: tested in a trial at high dose and did not show benefit sufficient to justify a larger study.
  • High-dose methylcobalamin, a form of vitamin B12, is the exception: a Japanese trial in people early in the disease showed a modest slowing of functional decline, and it was approved for ALS in Japan in 2024. It is not approved elsewhere, and the benefit was seen in a selected group treated early.
  • Vitamin D, omega-3 fats, curcumin and other polyphenols: no trial evidence of benefit in ALS. Correcting a measured deficiency is ordinary medicine.
  • Anything sold as a treatment or cure for ALS outside a clinical trial should be treated with great suspicion, and discussed with the neurology team, because some supplements interact with medicines.

Why it matters

Creatine and CoQ10 are worth knowing about specifically: they were tested properly, and they did not work. That is more useful information than untested enthusiasm.

What's still uncertain

  • Negative trials do not exclude small effects in subgroups, and research continues.

Read more

Next: Where to spend effort

Part 5 of 5

The honest priorities

Review of many studies

What happens

If energy and money are limited, this is where they go furthest.

What the research shows

  • Keeping weight on, with dietitian support, which has the best evidence of anything in this section.
  • Breathing support started at the right time.
  • A multidisciplinary clinic, which is associated with longer survival.
  • Clinical trial participation, which is how the treatments of the next decade get tested, and which many people find meaningful.
  • Equipment and communication technology arranged early, which preserves independence and the ability to take part in decisions.

Why it matters

Nutrition in ALS is one of the rare cases where the dietary advice is as well supported as the drugs. That is worth acting on.

What's still uncertain

  • Access to dietetic and specialist support varies widely.

Read more

More plain-language reading

See something wrong or unclear on this page? Suggest a correction. OwieClear is for education only and isn't medical advice.